vs
FIRST COMMUNITY BANKSHARES INC(FCBC)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是FIRST COMMUNITY BANKSHARES INC的1.6倍($69.8M vs $43.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 28.5%,领先355.6%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 5.1%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 3.5%)
第一社区银行控股公司是美国一家银行控股公司,总部位于弗吉尼亚州,为布卢菲尔德第一社区银行的母公司。截至2012年,该集团旗下网点分布在弗吉尼亚州、西弗吉尼亚州和田纳西州,截至2023年4月,集团总资产达36亿美元。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
FCBC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$43.8M
营收增速更快
RIGL
高出16.1%
5.1%
净利率更高
RIGL
高出355.6%
28.5%
两年增速更快
RIGL
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $43.8M | $69.8M |
| 净利润 | $12.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 36.8% | 33.2% |
| 净利率 | 28.5% | 384.0% |
| 营收同比 | 5.1% | 21.2% |
| 净利润同比 | -4.4% | 1769.2% |
| 每股收益(稀释后) | $0.67 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FCBC
RIGL
| Q4 25 | $43.8M | $69.8M | ||
| Q3 25 | $42.2M | $69.5M | ||
| Q2 25 | $41.0M | $101.7M | ||
| Q1 25 | $40.5M | $53.3M | ||
| Q4 24 | $41.7M | $57.6M | ||
| Q3 24 | $42.0M | $55.3M | ||
| Q2 24 | $41.3M | $36.8M | ||
| Q1 24 | $40.9M | $29.5M |
净利润
FCBC
RIGL
| Q4 25 | $12.5M | $268.1M | ||
| Q3 25 | $12.3M | $27.9M | ||
| Q2 25 | $12.2M | $59.6M | ||
| Q1 25 | $11.8M | $11.4M | ||
| Q4 24 | $13.0M | $14.3M | ||
| Q3 24 | $13.0M | $12.4M | ||
| Q2 24 | $12.7M | $-1.0M | ||
| Q1 24 | $12.8M | $-8.2M |
毛利率
FCBC
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
FCBC
RIGL
| Q4 25 | 36.8% | 33.2% | ||
| Q3 25 | 37.7% | 40.9% | ||
| Q2 25 | 38.6% | 60.1% | ||
| Q1 25 | 37.7% | 23.9% | ||
| Q4 24 | 39.6% | 28.9% | ||
| Q3 24 | 39.3% | 25.4% | ||
| Q2 24 | 39.3% | 1.2% | ||
| Q1 24 | 40.3% | -23.6% |
净利率
FCBC
RIGL
| Q4 25 | 28.5% | 384.0% | ||
| Q3 25 | 29.1% | 40.2% | ||
| Q2 25 | 29.9% | 58.6% | ||
| Q1 25 | 29.2% | 21.5% | ||
| Q4 24 | 31.3% | 24.9% | ||
| Q3 24 | 31.0% | 22.5% | ||
| Q2 24 | 30.8% | -2.8% | ||
| Q1 24 | 31.4% | -27.9% |
每股收益(稀释后)
FCBC
RIGL
| Q4 25 | $0.67 | $14.11 | ||
| Q3 25 | $0.67 | $1.46 | ||
| Q2 25 | $0.67 | $3.28 | ||
| Q1 25 | $0.64 | $0.63 | ||
| Q4 24 | $0.67 | $0.82 | ||
| Q3 24 | $0.71 | $0.70 | ||
| Q2 24 | $0.71 | $-0.06 | ||
| Q1 24 | $0.71 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $500.5M | $391.5M |
| 总资产 | $3.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
FCBC
RIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务
FCBC
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $0 | $60.0M | ||
| Q2 25 | $0 | $60.0M | ||
| Q1 25 | $0 | $60.0M | ||
| Q4 24 | $0 | $60.0M | ||
| Q3 24 | $0 | $60.0M | ||
| Q2 24 | $0 | $60.0M | ||
| Q1 24 | $0 | $60.0M |
股东权益
FCBC
RIGL
| Q4 25 | $500.5M | $391.5M | ||
| Q3 25 | $510.7M | $117.6M | ||
| Q2 25 | $502.8M | $81.9M | ||
| Q1 25 | $496.4M | $18.6M | ||
| Q4 24 | $526.4M | $3.3M | ||
| Q3 24 | $520.7M | $-14.6M | ||
| Q2 24 | $508.9M | $-29.9M | ||
| Q1 24 | $506.9M | $-31.7M |
总资产
FCBC
RIGL
| Q4 25 | $3.3B | $513.6M | ||
| Q3 25 | $3.2B | $242.5M | ||
| Q2 25 | $3.2B | $206.7M | ||
| Q1 25 | $3.2B | $176.0M | ||
| Q4 24 | $3.3B | $164.0M | ||
| Q3 24 | $3.2B | $139.4M | ||
| Q2 24 | $3.2B | $128.4M | ||
| Q1 24 | $3.2B | $126.5M |
负债/权益比
FCBC
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 0.00× | 0.73× | ||
| Q1 25 | 0.00× | 3.23× | ||
| Q4 24 | 0.00× | 18.25× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $62.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $60.0M | — |
| 自由现金流率自由现金流/营收 | 137.0% | — |
| 资本支出强度资本支出/营收 | 6.3% | — |
| 现金转化率经营现金流/净利润 | 5.03× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $100.6M | — |
8季度趋势,按日历期对齐
经营现金流
FCBC
RIGL
| Q4 25 | $62.7M | $22.0M | ||
| Q3 25 | $18.9M | $24.0M | ||
| Q2 25 | $10.2M | $30.5M | ||
| Q1 25 | $13.2M | $-893.0K | ||
| Q4 24 | $57.7M | $14.5M | ||
| Q3 24 | $11.4M | $21.7M | ||
| Q2 24 | $14.5M | $302.0K | ||
| Q1 24 | $16.9M | $-5.0M |
自由现金流
FCBC
RIGL
| Q4 25 | $60.0M | — | ||
| Q3 25 | $18.5M | — | ||
| Q2 25 | $10.0M | — | ||
| Q1 25 | $12.1M | — | ||
| Q4 24 | $54.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $14.1M | — | ||
| Q1 24 | $15.2M | — |
自由现金流率
FCBC
RIGL
| Q4 25 | 137.0% | — | ||
| Q3 25 | 43.9% | — | ||
| Q2 25 | 24.3% | — | ||
| Q1 25 | 29.8% | — | ||
| Q4 24 | 131.8% | — | ||
| Q3 24 | 26.0% | — | ||
| Q2 24 | 34.1% | — | ||
| Q1 24 | 37.1% | — |
资本支出强度
FCBC
RIGL
| Q4 25 | 6.3% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 4.4% | — |
现金转化率
FCBC
RIGL
| Q4 25 | 5.03× | 0.08× | ||
| Q3 25 | 1.54× | 0.86× | ||
| Q2 25 | 0.83× | 0.51× | ||
| Q1 25 | 1.12× | -0.08× | ||
| Q4 24 | 4.43× | 1.01× | ||
| Q3 24 | 0.88× | 1.75× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图